Drugs policy: medicinal cannabis inquiry
Inquiry by the Health and Social Care Committee, 6 December 2018 to 6 December 2018. Its page on the Parliament website.
Reports and responses
- 16th Report - Drugs policy: medicinal cannabis (3 July 2019)
- Drugs policy: medicinal cannabis: Government Response to the Committee's Sixteenth Report (6 September 2019)
Evidence sessions
- 19 March 2019: Professor Dame Sally Davies, Chief Medical Officer for England, Alette Addison, Head of Pharmacy Development and Regulation, Department of Health and Social CareGenevieve Edwards, Director of External Affairs, MS Society, Professor Mike Barnes, Interim Chair, Medical Cannabis Clinicians' Society, Peter Carroll, Campaign Director, End Our PainProfessor Helen Cross, Head of Developmental Neurosciences, UCL GOS Institute of Child Health, Dr Imran Malik, Committee member, Royal College of Psychiatrists, Professor Sanjay Sisodiya, Chair of the ABN Epilepsy Advisory Group, Association of British Neurologists
- 26 March 2019: Professor Andrew Goddard, President, Royal College of Physicians, Professor Finbar O'Callaghan, President, British Paediatric Neurology AssociationBaroness Blackwood, Parliamentary Under Secretary of State, Professor Chris Whitty, Chief Scientific Advisor, Department of Health and Social Care, Nick Hurd MP, Minister of State for Policing and the Fire Service, Home Office, Dr Keith Ridge, Chief Pharmaceutical Officer, NHS England